HEMOpALM

News

Portfolio

HemoPalm
UXD  
AUF

HemoPalm

HemoPalm is a handheld whole blood analyzer and single-use cartridge, with full hospital IT integration, which bring lab-quality blood analysis to the bedside in critical care.


Relay Medical Corp.'s HemoPalm IP enables a combination of full CO-oximetry and blood gases on a single use cartridge, in a handheld analyzer. Up until the early 1990s, many Laboratory blood gas analyzers and CO-oximeters were separate analyzers.  Currently, many Laboratory blood gas analyzers and CO-oximeters are integrated. HemoPalm intends to be the first company to integrate blood gases, electrolytes and CO-oximetry in one hand-held analyzer, using a consumable single use cartridge.

In 2014, the global POCT market for Blood Gases & Electrolytes was estimated to be $1.5 Billion.  Laboratory and cart-carried Blood Gases & Electrolytes analyzers have evolved over the years to provide CO-oximetry and Bilirubin, but hand-held analyzers have not evolved like the larger analyzers.  HemoPalm is positioned to be the only hand-held analyzer that will provide Blood Gases, Electrolytes, CO-oximetry and Bilirubin in a single disposable cartridge.

Our productization strategy is to evolve the HP as a “total solution” for the defined clini-commercial application; patients in a critical care setting.
— Lahav Gil

The HemoPalm IP integrates full CO-oximetry, measured through spectroscopy, which allows the user to measure total hemoglobin (Hb), Oxy-Hb, Deoxy-Hb, Met-Hb and carboxy-Hb, simultaneously with blood gases and electrolytes measured with electrochemical sensors, from the same blood sample on the same cartridge.  CO-oximetry has traditionally been performed using bench-top analyzers that are large, expensive, and usually located in central laboratories. There are many benefits to providing these blood tests near or at the point of care of patients, but these benefits are not realized due to the size and cost of the bench-top analyzers. In addition, the blood sample can be collected directly into the cartridge from a finger prick or, in the case of neonatals, a heel prick-prick, as an alternative to an arterial sample taken with a syringe, which makes the technology applicable in the markets outside of a main stream clinical setting like first responders, military, emerging economies and disaster relief.  These are all areas where central labs are simply not available.  In the hospital setting it allows rapid patient analysis in situations like emergency department triage.